Experimental Cholesterol Pill Cuts Heart Attack Risk with 'Convenient' Once-Daily Dose
4 Articles
4 Articles
Experimental cholesterol pill cuts heart attack risk with 'convenient' once-daily dose
A new daily pill could provide an easier, more convenient way to lower cholesterol and reduce heart attack and stroke risk. The experimental medication, called Obicetrapib, underwent a Phase 3 clinical trial at Monash University in Australia. The trial included more than 2,500 people averaging 65…
Experimental cholesterol pill cuts heart attack risk with 'convenient' once-daily dose – Democratic Accent
A new daily pill could provide an easier, more convenient way to lower cholesterol and reduce heart attack and stroke risk. The experimental medication, called Obicetrapib, underwent a Phase 3 clinical trial at Monash University in Australia. The trial included more than 2,500 people averaging 65 years of age. All had either been diagnosed with heart disease or had genetically high cholesterol, according to a university press release. THIS CHEA…
This heart problem may strongly increase heart attack and stroke risks
Atrial Fibrillation, or AF for short, is a heart condition that causes the heart to beat irregularly—sometimes too fast, sometimes too slow. It affects millions of people and has been a growing focus of research in the UK. While AF itself isn’t always life-threatening, it raises the risk of serious complications like stroke and heart […] The post This heart problem may strongly increase heart attack and stroke risks appeared first on Knowridge S…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium